Agata M. Bogusz

SYK Inhibition Modulates Distinct PI3K/AKT- Dependent Survival Pathways and Cholesterol Biosynthesis in Diffuse Large B Cell Lymphomas

Lin‐Feng Chen, Stefano Monti, Przemysław Juszczyński et al. · Cancer Cell · 2013 · 170 citations · Full text

Cholesterol Biosynthesis, Lymphoid Neoplasia, Receptor Tyrosine Kinase +8

A novel N‐terminal hydrophobic motif mediates constitutive degradation of serum‐ and glucocorticoid‐induced kinase‐1 by the ubiquitin–proteasome pathway

Agata M. Bogusz, Deanna R. Brickley, Travis Pew et al. · FEBS Journal · 2006 · 56 citations · Full text

Proteasome, Cell Death, Signaling Pathway +18

Cyclin D1 expression and novel mutational findings in Rosai‐Dorfman disease

Ezra Baraban, Sam Sadigh, Jason N. Rosenbaum et al. · British Journal of Haematology · 2019 · 55 citations

Brentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomas

Jakub Svoboda, Steven M. Bair, Daniel J. Landsburg et al. · Haematologica · 2020 · 51 citations · Full text

Immunology, Pathology, Metronomic Chemotherapy +18

Quantitative Immunofluorescence Reveals the Signature of Active B-cell Receptor Signaling in Diffuse Large B-cell Lymphoma

Agata M. Bogusz, Richard H. G. Baxter, Treeve Currie et al. · Clinical Cancer Research · 2012 · 47 citations · Full text